|
Volumn 28, Issue 1, 2014, Pages 32-38
|
Serum concentration of vascular endothelial growth factor after bilateral intravitreal injection of bevacizumab
|
Author keywords
Bevacizumab; Intravitreal injections; Vascular endothelial growth factor
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
VASCULOTROPIN A;
ANTAGONISTS AND INHIBITORS;
BLOOD;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FOLLOW UP;
INTRAVITREAL DRUG ADMINISTRATION;
MACULAR DEGENERATION;
OPTICAL TOMOGRAPHY;
PATHOLOGY;
PROSPECTIVE STUDY;
RETINA MACULA LUTEA;
TREATMENT OUTCOME;
VISUAL ACUITY;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FOLLOW-UP STUDIES;
INTRAVITREAL INJECTIONS;
MACULA LUTEA;
MACULAR DEGENERATION;
PROSPECTIVE STUDIES;
TOMOGRAPHY, OPTICAL;
TREATMENT OUTCOME;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VISUAL ACUITY;
|
EID: 84912012271
PISSN: 10118942
EISSN: None
Source Type: Journal
DOI: 10.3341/kjo.2014.28.1.32 Document Type: Article |
Times cited : (14)
|
References (0)
|